Thanks for reporting the interview.
I listened to it and was intending to. Now I don’t have to.
The NZ Hepatitis Foundation has posted similar stuff on it’s website recently:
http://www.hepatitisfoundation.org.nz/index.php/events/personal-importation-hepatitis-c-medicines-position-statement-hepatitis-foundation-new-zealand/
I am curious about the concern raised about non-licensed Harvoni equivalents which many of us are taking.
Is this Gilead friendly fear-mongering or is there any real evidence?
In an email to me from Monkmed a possibly related concern was raised:
“Twinvir is not licensed and lot of people reporting side effects. We only ship GILEAD licensed products like HepcVir L and Hepcinat LP”

That’s worrying…….will make the next 12 weeks’ wait (post treatment) a bit more stressful

I really wouldn’t worry at all about Prof Gane’s comments if you went through Buyers Club. He was making a strong case for people not shopping themselves on the internet and the sort of dangers that could come up. It is just a responsible warning. In the context of everything else he said, it was showing the difference between that kind of online medication purchase and the secure supply through Redemption and Buyers Club. The first part of the interview was Dr James and he addressed the same issues. SVR12 here is as secure as a govt purchased trial or treatment.

Chinese Ledipasvir is part of my treatment…..I really don’t know what to make of all of this….wish I hadn’t of read it to be honest. To relapse would be devastating.

Hi Chapel,

I can’t find the relevant post (maybe you can?) but from memory Dr Freeman noted that Gilead had in fact used a slightly different form of Ledipasvir (#NOTE: my error, the differing DAA was Sofosbuvir per Chapel’s post below) in their production Harvoni to what they had trialled and the Mesochem product was the same as was used during their approval trials.

But really, the quote from Ed is a few sentences of caution in a 10 min or so chat and is mostly directed at “They could be fake, they could be diluted so not as effective, they could be contaminated…….” so talking about sourcing outside of reliable supply chain. He also comments on the non licensed generics but very generally (without pointing fingers other than at countries that didn’t accept the patents) as I would expect someone who works in the field of clinical trials researcher with a number of patent holding pharma companies to do. There is nothing untoward in this nor any implications against him in my mentioning it. It is simply a fact of research/commercial reality if we want wonderful new drugs like these DAAs developed and trialled. I find his caution in that regard entirely understandable, he can be confident in the efficacy of patent drugs for his patients.

Look,its natural we all faced anxiety when we started as we finish we also face the
same anxieties when we read someone in the business ,we think. Hmm.

I am 100% confident, everyone who has reached UD will go ahead and be UD at SVR therefore
cured I include myself in that.

I actually think this particular DR if he had such great concern run should have Run a Trial of generics instead
of making a bunch of folk worry!

Oh,hang on there is a Dr doing a Trial its James Freeman ,I think the stats will speak for themselves along
with all of us becoming cured from generics.

Ps. I don’t think the sob would sustain so many people to be UD unless the Led was also
working the research suggests Sob on its own has it down to the 60/70 % for G 1 I would
think quite a few showed 12 at best then failed outright after treatment.

Lynn, I am confident you’re on track and will be fine.

Just wondering does the Professor have any affiliation with the gilead sof/vel trials ocurring in NZ at present? Em